Zoetis ZTS 深沪

等待开盘 08-10 09:30:00 美东时间

72.635

-4.595

-5.95%

华盛通

立即下载

最高79.60
今开78.18
成交量 1171.35万股
最低 72.19
昨收 77.23
总市值 3421.11万
52周最高 160.48
市盈率 ^静 17.00
换手率 2486.93%
52周最低 71.47
委比 -23.66%
总股本 0.00亿
历史最高 248.62
量比 1.58
振幅 9.59%
历史最低 22.852
每手 1
风险率 25.85%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

Zoetis' Acquisition of Neogen Genomics Business Faces Regulatory Scrutiny in Australia

The Australian agency is conducting a Phase 2 assessment of Zoetis' $160 million acquisition of Neogen's genomics unit due to competition concerns.

07-17 21:57
Argus Research Downgrades Zoetis to Hold

Argus Research analyst Jasper Hellweg downgrades Zoetis (NYSE:ZTS) from Buy to Hold.

05-27 19:51
Analysts Question Zoetis' Pathway To Growth As Key Segments Slide

Animal health firm Zoetis Inc. (NYSE: ZTS) reports Q4 2025 earnings, with adjusted EPS of $1.48 beating consensus of $1.40.

02-13 02:24
Earnings Scheduled For February 12, 2026

Companies Reporting Before The Bell • Ambev (NYSE:ABEV) is estimated to report ...

02-12 19:11
Robinhood, AppLovin, Rivian and More Stocks With Earnings This Week

Investors are anticipating reports from Robinhood, Pinterest, Rivian and more. Here's a look at the earnings calendar for the week ahead.

02-10 00:30
辉瑞恋战减肥药

■本报记者刘晓诺北京报道　　　　在减肥药开发路上屡败屡战的辉瑞，再斥重金购买中国创新药。不过，“宇宙第一大药厂”理想的胖友，似乎不只有人类。 2025年...

2025-12-12 22:01
Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst

KeyBanc initiates Zoetis at Sector Weight, citing OA drug headwinds, rising competition, and limited near-term catalysts despite strong fundamentals.

2025-11-22 01:24
Keybanc Initiates Coverage On Zoetis with Sector Weight Rating

Keybanc analyst Steve Dechert initiates coverage on Zoetis (NYSE:ZTS) with a Sector Weight rating.

2025-11-21 21:51
Zoetis Stock Outlook Clouded By Rising Competitive Pressures

Zoetis tops Q3 earnings estimates but trims 2025 sales forecast as companion animal growth slows and competition weighs on its outlook.

2025-11-05 02:15
Zoetis' Portela Granted European Commission's Marketing Authorization

Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Portela® (relfovetmab), making it the first monoclonal antibody (mAb) therapy with a three-month dosing

2025-10-29 20:34

派息除权日	每股总股息	派息日期
2022-07-20	0.32	2022-09-01
2022-04-20	0.32	2022-06-01
2022-01-19	0.32	2022-03-01
2021-10-28	0.25	2021-12-01
2021-07-20	0.25	2021-09-01
2021-04-20	0.25	2021-06-01
2021-01-19	0.25	2021-03-01
2020-10-20	0.20	2020-12-01
2020-07-16	0.20	2020-09-01
2020-04-16	0.20	2020-06-01
2020-01-16	0.20	2020-03-03
2019-10-21	0.16	2019-12-02
2019-07-18	0.16	2019-09-03
2019-04-17	0.16	2019-06-03
2019-01-17	0.16	2019-03-01
2018-11-19	0.13	2018-12-03
2018-07-19	0.13	2018-09-04
2018-04-19	0.13	2018-06-01
2018-01-18	0.13	2018-03-01
2017-11-08	0.10	2017-12-01
2017-06-13	0.10	2017-09-01
2017-04-04	0.10	2017-06-01
2017-01-18	0.10	2017-03-01
2016-11-01	0.09	2016-12-01
2016-06-28	0.09	2016-08-30
2016-04-05	0.09	2016-06-01
2016-01-19	0.09	2016-03-01
2015-11-03	0.08	2015-12-01
2015-08-11	0.08	2015-09-01
2015-04-07	0.08	2015-06-02
2015-01-20	0.08	2015-03-03
2014-11-03	0.07	2014-12-02
2014-08-18	0.07	2014-09-02
2014-04-24	0.07	2014-06-02
2014-01-28	0.07	2014-03-04
2013-10-30	0.06	2013-12-02
2013-07-30	0.06	2013-09-02
2013-04-29	0.06	2013-06-06

公司名称	Zoetis
行业分类	制药
业务描述	硕腾，作为一家全球领先的动物保健公司，致力于为客户及其业务提供最有力的支持。秉承60 年的悠久历史，硕腾为用户提供优质的兽药和疫苗、业务支持和技术培训。我们始终不懈努力，并帮助饲养和关爱动物的人们，为他们解决所面临的各种挑战。硕腾的英文名字Zoetis (zō-EH-tis)，其词根为zo，以 zoo（动物园）和zoology（动物学）而广为人知。Zoetis源于zoetic（有生命的，有生气的），蕴含“赋予生命的意义”之义。硕腾（Zoetis）致力于为世界各地的饲养和关爱动物的兽医和畜牧从业人员提供支持。

Zoetis ZTS 深 沪

72.635

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Zoetis ZTS 深沪